We are addressing this need though generation, testing and publicising our new safe and effective peptide-based therapeutics for type 2 diabetes. We make use of naturally occurring peptide hormones ...
Glucagon-like peptide-1 (GLP-1) receptor agonists (also called “glutides”) are an effective treatment for patients with type 2 diabetes and chronic kidney disease In a randomized controlled trial of ...